Prescribing costs in general practice continue to grow. Their importance is underlined by the
amount of information concerned with costs that general practitioners (GPs) receive, and by …

The rising costs of pharmaceutical expenditures are a common problem for policy makers in
most European countries. In two countries, budget systems for pharmaceutical spending …

Reports on a small‐scale study of 30 general practitioners and 30 specialists in Greece
where pharmaco‐economic information was presented to these prescribers and an attempt …

Objectives: Our main objective is to examine whether the Japanese government's
pharmaceutical price reduction policy has reduced the size of pharmaceutical profit …

The Danish health care system is decentralized and tax financed. Reimbursable drugs are
financed by the national health insurance, which despite its official name, is a taxfunded …

The German health care reform of 1997 provides a natural experiment for evaluating the
price sensitivity of demand for physicians' services. As a part of the reform, co‐payments for …

Although not a member of the EU, Norway participates in the European-wide regulatory
framework for granting marketing authorization to pharmaceutical products. Maximum prices …

Concern about the size of the NHS drugs bill in the UK has resulted in three main policy
initiatives by government: regular increases in prescription charges, the introduction of …

Objective: To document the influence of hospital prescribers on prescribing in general
practice. Design and Participants: Five percent of members of the Irish College of General …

This paper examines how demand for prescription drugs is influenced by different types of
insurance. In order to understand demand characteristics and the competitiveness of …